Transcriptomics

Dataset Information

0

An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses

ABSTRACT: By harnessing B16-derived immunologically ‘cold’ tumor models, we assessed therapeutic effects of ORFV recombinants .

ORGANISM(S): Mus musculus

PROVIDER: GSE339043 | GEO | 2026/08/11

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics Oncolytic ORFV induces antitumor immunity
2022-12-09 | GSE206634 | GEO
Genomics Oncolytic ORFV induces antitumor immunity
| PRJNA851624 | ENA
Genomics
| PRJNA1083465 | ENA
Unknown Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity.
| S-EPMC3554062 | biostudies-literature
Unknown Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
| S-EPMC6052588 | biostudies-literature
Genomics An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses
| PRJNA1496858 | ENA
Unknown Novel oncolytic adenovirus-based PEPvIII vaccine displays a super antitumor effect in glioma models.
| S-EPMC12481307 | biostudies-literature
Unknown A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses.
| S-EPMC11286824 | biostudies-literature
Unknown Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia.
| S-EPMC7181830 | biostudies-literature
Unknown Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution.
| S-EPMC9126185 | biostudies-literature